Restylane Kysse with Lido (1x1 ml)

Patients should avoid alcohol for at least 24 hours before and after treatment to minimize vasodilation, bruising, and swelling.

Contraindicated during pregnancy. There are no adequate controlled studies evaluating filler safety in pregnant patients; elective procedures should be postponed until after delivery.

Not recommended while breastfeeding due to insufficient data on HA metabolite excretion in breast milk.
Treatment should be deferred until the completion of the breastfeeding period.

Inject small aliquots into the superficial to mid-dermis or submucosal layer of the lips using linear threading, serial puncture, or fanning technique.
Adjust injection depth and volume according to the patient’s anatomy and desired correction.
Always aspirate prior to injection, proceed slowly, and avoid intravascular placement. Maintain aseptic technique throughout the procedure.

Common post-treatment reactions include mild redness, swelling, tenderness, or bruising at the injection site, typically resolving within several days.
Rare but serious complications such as vascular occlusion, blanching, severe pain, or visual disturbances require immediate medical attention.
Cold compresses and avoiding pressure or heat for 24–48 hours may help reduce localized reactions.

Cross-linked hyaluronic acid binds and retains water molecules, restoring hydration and volume to the lips and surrounding tissue.
The Optimal Balance Technology™ ensures a balanced viscosity and elasticity profile, enabling seamless tissue integration and natural-looking flexibility during facial expression.
Over time, the gel biodegrades completely, leaving improved lip texture and suppleness.

Cross-linked Hyaluronic Acid (20 mg/ml) and Lidocaine (0.3%) for patient comfort and procedural ease.
Non-animal stabilized HA designed for precision shaping, flexibility, and natural tissue harmony.